Molina Healthcare, Inc. reported a significant decline in its financial performance for the first quarter of 2026, with net income falling to $14 million, or $0.27 per diluted share, compared to $298 million, or $5.45 per diluted share, in the same period last year. Total revenue decreased by 3.1% to $10.8 billion, down from $11.1 billion in the first quarter of 2025. The decline in premium revenue, which fell by 4% to $10.2 billion, was attributed to a reduction in membership, particularly in the Medicaid segment, and the expiration of the Virginia Medicaid contract. The company's consolidated medical care ratio (MCR) increased to 91.1%, up from 89.2% in the prior year, reflecting higher medical costs amid a challenging healthcare environment.
In terms of operational metrics, Molina's membership decreased by 718,000, or 12%, year-over-year, totaling approximately 5.0 million members as of March 31, 2026. This decline was primarily driven by market contraction in Medicaid and a strategic shift in the company's product offerings. The company also recognized a $93 million impairment charge related to its planned exit from the Medicare Advantage-Prescription Drug (MAPD) product line, which is set to take effect in 2027. The general and administrative expense ratio rose to 7.2%, compared to 6.9% in the previous year, due to timing of certain operating expenses.
Molina's operational developments included the successful transition of Medicare-Medicaid Plan (MMP) members to integrated dual-eligible special needs plans across five states, which is expected to enhance the company's focus on dual-eligible members. The company also secured new contracts in several states, including Michigan, Massachusetts, and Ohio, which commenced on January 1, 2026. However, the overall membership in the Marketplace segment decreased significantly, with only 305,000 members reported, down from 662,000 a year earlier, as part of a strategic decision to restore target margins.
Looking ahead, Molina Healthcare anticipates further challenges in its Medicaid segment, projecting a decrease in enrollment to approximately 4.5 million members by the end of 2026. The company expects to offset some revenue losses through higher Marketplace revenue, with a revised estimate of 250,000 members by year-end. The ongoing legislative changes, particularly those stemming from the One Big Beautiful Bill Act, are expected to impact enrollment and revenue in the Medicaid and Marketplace segments. Molina's management remains focused on organic growth and strategic acquisitions to enhance its operational capabilities and financial performance in the coming quarters.
About MOLINA HEALTHCARE, INC.
Molina Healthcare is a Fortune 500 company providing managed healthcare services primarily through Medicaid, Medicare, and Marketplace programs. It offers comprehensive health plans, including Medicaid managed care, Medicare Advantage, and ACA-compliant Marketplace coverage. Serving millions across 21 states, Molina emphasizes high-quality, cost-effective care, extensive provider networks, and innovative operational efficiencies, including AI initiatives, to deliver reliable, government-sponsored health services.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.